Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Home oxygen with high-flow therapy vs standard oxygen for chronic lung and heart disease

Official title: Advanced Bedside Lung Imaging and Respiratory Muscle Monitoring for Respiratory Support Management in Chronically Ill Patients With Acute Respiratory Failure: From Hospital to Home

Run by Università degli Studi di Ferrara · NCT07157696 · Data updated 2026-11-12

In people with long-term lung or heart conditions who need oxygen after leaving the hospital, the study tests whether a high-flow nasal cannula (HFNC) can improve breathing comfort and quality of life compared with standard oxygen therapy.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment16 (estimated)
SponsorUniversità degli Studi di Ferrara
Academic / other
Locations1 site (Ferrara, Italy)
StatusRecruiting
StartedNovember 5, 2025
Main results expectedDecember 31, 2026
Study endsJanuary 30, 2027
Registry record updatedOctober 8, 2026
Trial IDNCT07157696 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with chronic respiratory and/or cardiac disease who need long-term oxygen therapy and can manage home devices (with or without a caregiver).

Probably not a fit

Patients with very limited life expectancy or those unable to comply with home follow-up may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial compares two home oxygen strategies in adults with chronic respiratory or cardiac disease who require long-term oxygen. Participants will alternate two-week periods of HFNC therapy using the myAirvo3 device and standard oxygen therapy, with a short break between periods, to directly compare effects within the same person. Remote monitoring will track oxygen levels, heart rate, symptoms, and sleep to help researchers understand tolerability and potential benefits. A wearable device will monitor night-time breathing pauses and heart rhythm. The study aims to determine whether HFNC provides better comfort and daily functioning than standard oxygen in a home setting.

Why it matters

Potential benefit: If HFNC proves more comfortable and easier to use, patients could experience better breathing relief and quality of life at home.

How similar studies have gone: Previous research in related settings suggests potential advantages of HFNC for comfort and sleep, but results for home oxygen in chronic disease populations are still being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥18 years) with chronic respiratory (e.g., COPD, interstitial lung disease) and/or cardiac disease (e.g., heart failure),
* Clinical indication for long-term oxygen therapy,
* Capability to manage home-based devices independently or with caregiver assistance
* Signed informed consent

Exclusion Criteria:

* Life expectancy \< 3 months
* Inability to comply with home follow-up procedures.

Where it's running

  • Savino SPADARO
    Ferrara, Italy, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.